119 related articles for article (PubMed ID: 12593941)
21. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
Paudel A; Loyson Y; Van den Mooter G
J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
[TBL] [Abstract][Full Text] [Related]
22. Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD.
Granero G; de Bertorello MM; Longhi M
Boll Chim Farm; 2002; 141(1):63-6. PubMed ID: 12064060
[TBL] [Abstract][Full Text] [Related]
23. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
[TBL] [Abstract][Full Text] [Related]
24. Thermal analysis and spectroscopic characterization of interactions between a naphthoquinone derivative with HP-beta-CD or PVP.
Granero G; Longhi M
Pharm Dev Technol; 2002; 7(3):381-90. PubMed ID: 12229269
[TBL] [Abstract][Full Text] [Related]
25. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
[TBL] [Abstract][Full Text] [Related]
26. Application of supercritical carbon dioxide for the preparation of a piroxicam-beta-cyclodextrin inclusion compound.
Van Hees T; Piel G; Evrard B; Otte X; Thunus L; Delattre L
Pharm Res; 1999 Dec; 16(12):1864-70. PubMed ID: 10644075
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization.
Cirri M; Maestrelli F; Corti G; Furlanetto S; Mura P
J Pharm Biomed Anal; 2006 Sep; 42(1):126-31. PubMed ID: 16406448
[TBL] [Abstract][Full Text] [Related]
28. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
29. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
30. Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology.
Lu Y; Tang N; Qi J; Wu W
Pharm Dev Technol; 2012; 17(2):236-41. PubMed ID: 21067338
[TBL] [Abstract][Full Text] [Related]
31. Investigation of water-soluble inclusion complex of hypericin with β-cyclodextrin polymer.
Zhang W; Gong X; Cai Y; Zhang C; Yu X; Fan J; Diao G
Carbohydr Polym; 2013 Jun; 95(1):366-70. PubMed ID: 23618281
[TBL] [Abstract][Full Text] [Related]
32. Formulation of Curcumin-β-cyclodextrin-polyvinylpyrrolidone supramolecular inclusion complex: experimental, molecular docking, and preclinical anti-inflammatory assessment.
Jafar M; Khalid MS; Aldossari MFE; Amir M; Alshaer FI; Adrees FAA; Gilani SJ; Alshehri S; Hassan MZ; Imam SS
Drug Dev Ind Pharm; 2020 Sep; 46(9):1524-1534. PubMed ID: 32808552
[TBL] [Abstract][Full Text] [Related]
33. Driving forces and the influence of the buffer composition on the complexation reaction between ibuprofen and HPCD.
Perlovich GL; Skar M; Bauer-Brandl A
Eur J Pharm Sci; 2003 Oct; 20(2):197-200. PubMed ID: 14550885
[TBL] [Abstract][Full Text] [Related]
34. Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion.
Dalmora ME; Oliveira AG
Int J Pharm; 1999 Jul; 184(2):157-64. PubMed ID: 10387944
[TBL] [Abstract][Full Text] [Related]
35. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
36. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
Hegge AB; Másson M; Kristensen S; Tønnesen HH
Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
[TBL] [Abstract][Full Text] [Related]
37. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.
Govindarajan R; Nagarsenker MS
J Pharm Pharmacol; 2004 Jun; 56(6):725-33. PubMed ID: 15231037
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen.
Zerrouk N; Mennini N; Maestrelli F; Chemtob C; Mura P
Eur J Pharm Biopharm; 2004 Jan; 57(1):93-9. PubMed ID: 14729084
[TBL] [Abstract][Full Text] [Related]
39. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
40. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]